Mereo BioPharma investors face securities class action deadline

Investors in Mereo BioPharma Group plc are being alerted to an upcoming deadline for a securities class action lawsuit. Faruqi & Faruqi, LLP, a prominent national securities law firm, is investigating potential claims against the company. This investigation suggests possible allegations of misconduct or misrepresentation that may have impacted shareholders. The deadline for investors to participate in or be aware of this legal action is April 6, 2026, highlighting a critical period for those affected by the company's stock performance.